A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
EARLY_PHASE1
This is a single arm, open-label, single center study to determine the safe...
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
PHASE2
Evaluate the safety and efficacy of Inaticabtagene autoleucel combined with...
Status
Recruiting
Location
National Institute of Hematology, Chinese Academy of Medical Sciences